AbbVie (ABBV) Acquisitions (2012 - 2025)
AbbVie (ABBV) reported Acquisitions of $204.0 million for Q1 2025, down 97.78% year-over-year from $9.2 billion in Q1 2024, and down 97.54% quarter-over-quarter from $8.3 billion in Q3 2024.
AbbVie (ABBV) Acquisitions (2012 - 2025) Analysis & Trends
AbbVie (ABBV) has 10 years of Acquisitions data on file, last reported at $204.0 million in Q1 2025.
- Acquisitions for Q1 2025 came in at $204.0 million, down 97.78% year-over-year; the trailing twelve-month figure through Dec 2025 was $204.0 million (down 98.83% YoY), and the FY2025 annual result was $204.0 million, down 98.83% from the prior year.
- Acquisitions eased to $204.0 million in Q1 2025 per ABBV's latest filing, from $8.3 billion in the prior quarter.
- Over five years, Acquisitions peaked at $9.2 billion in Q1 2024 and troughed at $204.0 million in Q1 2025.
- A 3-year average of $4.6 billion and a median of $4.4 billion in 2021 frame the typical range for Acquisitions.
- The sharpest annual moves came in 2021 and 2025: Acquisitions surged 330.33% in 2021, then sank 97.78% in 2025.
- A 3-year view of Acquisitions shows it stood at $525.0 million in 2021, then surged by 1479.81% to $8.3 billion in 2024, then sank by 97.54% to $204.0 million in 2025.
- Business Quant data shows ABBV's Acquisitions at $204.0 million in Q1 2025, $8.3 billion in Q3 2024, and $9.2 billion in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 93,699,046.73 Bn | 93,699,041.77 Bn | 7.76 Bn | -1.89 Bn |
| 2 | Eli Lilly | 1,012.06 Bn | 1,006.77 Bn | 16.22 Bn | - |
| 3 | Johnson & Johnson | 560.67 Bn | 538.62 Bn | 15.96 Bn | - |
| 4 | AbbVie | 402.20 Bn | 392.85 Bn | 10.78 Bn | - |
| 5 | Merck | 298.59 Bn | 292.94 Bn | 12.09 Bn | 8.78 Bn |
| 6 | Amgen | 188.77 Bn | 176.74 Bn | 5.87 Bn | - |
| 7 | Gilead Sciences | 160.22 Bn | 152.49 Bn | 5.52 Bn | 109.00 Mn |
| 8 | Pfizer | 148.19 Bn | 135.42 Bn | -1.21 Bn | - |
| 9 | Bristol Myers Squibb | 116.72 Bn | 106.26 Bn | 8.07 Bn | 65.00 Mn |
| 10 | Novartis Ag | 109.78 Bn | 109.09 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 204.00 Mn |
| Sep 30, 2024 | 8.29 Bn |
| Mar 31, 2024 | 9.20 Bn |
| Dec 31, 2021 | 525.00 Mn |
| Dec 31, 2020 | 122.00 Mn |
| Jun 30, 2017 | -63.00 Mn |
| Mar 31, 2017 | 63.00 Mn |
| Dec 31, 2016 | 18.00 Mn |
| Sep 30, 2016 | 22.00 Mn |
| Jun 30, 2016 | 2.43 Bn |
| Mar 31, 2016 | 28.00 Mn |
| Jun 30, 2015 | 10.75 Bn |
| Mar 31, 2015 | 736.00 Mn |
| Dec 31, 2014 | 50.00 Mn |
| Sep 30, 2014 | 555.00 Mn |
| Dec 31, 2013 | 47.00 Mn |
| Sep 30, 2013 | 224.00 Mn |
| Jun 30, 2013 | 134.00 Mn |
| Dec 31, 2012 | -92.00 Mn |
| Jun 30, 2012 | 109.00 Mn |